Management of XXXX .

@entity1 @entity171 @entity174 @entity2931 @entity14577 @entity604 @entity170 @entity460 @entity1388 @entity3800
@entity170 is clearly more easily prevented than treated. Prevention should start early for those thought to be most at risk. However, for the majority, menopause is the most convenient time point at which to evaluate the necessity for prevention. While @entity2931 are the most effective therapeutic agent for prevention of @entity14577 , they must be used judiciously with attention to reduction in other nutritional and lifestyle risk factors. When given to @entity1 with an intact uterus, @entity2931 prescription currently should be accompanied by progestogens, several of which may also reduce @entity604 . All individuals should be encouraged to obtain an adequate @entity460 intake (100-1500 mg day-1) and to continue an active lifestyle. Therapy of the clinically overt disorder follows similar guidelines, with therapeutic options including calcitonin @entity3800 and @entity171 as well as @entity2931 as antiresorptive agents. Methods of stimulating new bone formation are limited, the best documented effects being those of @entity1388 . However, care must be taken in its use and efficacy has yet to be finally established. Other modalities are as yet experimental. Much can be gained by careful attention to the general health of the @entity1 and their environment, since reduction in risk of falls, and thus @entity174 , is at least as important as attempts to modify the skeleton.
